Gall-bladder agenesis presenting with obstructive jaundice and elevated CA 19-9

被引:7
作者
Trompetas, V [1 ]
Panagopoulos, E [1 ]
Ramantanis, G [1 ]
机构
[1] St Savvas Anticancer Hosp, Dept Surg 2, Athens, Greece
关键词
gall-bladder; abnormalities; CA; 19-9; antigen; choledocholithiasis; agenesis; jaundice; cholestatic;
D O I
10.1080/00015458.2004.11679571
中图分类号
R61 [外科手术学];
学科分类号
摘要
We report the case of an 81-year-old man with agenesis of the gall-bladder that presented with choledocholithiasis, obstructive jaundice, and very high CA 19-9 serum level (2765 U/ml). On ultrasound and CT scan, the gallbladder was not visualised and it was assumed shrunken and filled with gall-stones. After repeated unsuccessful endoscopic retrograde cholangiopancreatography, the patient was operated on for common bile duct (CBD) stones. At laparotomy the gall-bladder was not identified but a 3 cm long gall-stone was removed from the CBD. After decompression of the CBD all symptoms disappeared and the CA 19-9 returned to normal. We believe that this is the first report in the literature of gall-bladder agenesis presenting with high serum level of CA 19-9.
引用
收藏
页码:347 / 349
页数:3
相关论文
共 14 条
  • [1] ELEVATED SERUM LEVELS OF TUMOR-MARKER CA19-9 IN ACUTE CHOLANGITIS
    ALBERT, MB
    STEINBERG, WM
    HENRY, JP
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (10) : 1223 - 1225
  • [2] AZMAT N, 1993, AM J GASTROENTEROL, V88, P1269
  • [3] EXTRAHEPATIC CHOLESTASIS DETERMINES A REVERSIBLE INCREASE OF GLYCOPROTEIC TUMOR-MARKERS IN BENIGN AND MALIGNANT DISEASES
    BASSO, D
    MEGGIATO, T
    FABRIS, C
    PLEBANI, M
    FOGAR, P
    PANOZZO, MP
    DELFAVERO, G
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (12) : 800 - 804
  • [4] BENNION RS, 1988, ARCH SURG-CHICAGO, V123, P1257
  • [5] Isolated agenesis of the gallbladder: Report of a case
    Fisichella, PMA
    Di Stefano, A
    Di Carlo, I
    La Greca, G
    Russello, D
    Latteri, F
    [J]. SURGERY TODAY, 2002, 32 (01) : 78 - 80
  • [6] JACKSON RJ, 1989, AM SURGEON, V55, P36
  • [7] Jain B K, 2001, Trop Gastroenterol, V22, P80
  • [8] The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA
    Maestranzi, S
    Przemioslo, R
    Mitchell, H
    Sherwood, RA
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1998, 35 : 99 - 103
  • [9] OSSWALD BR, 1993, DIS MARKERS, V11, P275, DOI 10.1155/1993/234238
  • [10] RICHARDS RJ, 1993, J CLIN GASTROENTEROL, V16, P231